CASE_ID,SUBMITTER,PATIENT__CENTRIC__OBSERVATION,PATIENT__CENTRIC__OBSERVATION__VALUE,SPECIMEN__COLLECTION__DTTM,FILLER__ORDER__NUM,TEST__RESULT,TEST__REQUEST__NOTE
101,UW,SEQUENCING STUDY IDENTIFIER,WA-CDC-UW6903,2026-03-15,S9659,SARS-CoV-2 VJ.4.4 lineage,**SEQREA**SENTINEL SURVEILLANCE**SEQREA**
102,UW,SEQUENCING STUDY IDENTIFIER,WA-CDC-UW5274,2025-01-15,M6069,SARS-CoV-2 RA.3.1.12 lineage,**SEQREA**SENTINEL SURVEILLANCE**SEQREA**
103,UW,SEQUENCING STUDY IDENTIFIER,WA-CDC-UW3609,2025-04-19,T8904,SARS-CoV-2 BZ.5.9 lineage,**SEQREA**SENTINEL SURVEILLANCE**SEQREA**
104,Quest,Sequencing study identifierAllowable,WA-QDX-5168,2024-10-13,5168,SARS-CoV-2 HGM.6.1.7 lineage,
104,Quest,Original Submitter Lab SpecimenID,OW9455W,2024-10-13,5168,SARS-CoV-2 HGM.6.1.7 lineage,
104,Quest,,,2024-10-13,5168,SARS-CoV-2 HGM.6.1.7 lineage,
105,Quest,Sequencing study identifierAllowable,WA-QDX-9582,2024-05-25,9582,SARS-CoV-2 OG.6.11 lineage,
105,Quest,Original Submitter Lab SpecimenID,OW9841W,2024-05-25,9582,SARS-CoV-2 OG.6.11 lineage,
105,Quest,,,2024-05-25,9582,SARS-CoV-2 OG.6.11 lineage,
106,Quest,Sequencing study identifierAllowable,WA-QDX-5383,2023-11-06,5383,SARS-CoV-2 EU.4.13 lineage,
106,Quest,Original Submitter Lab SpecimenID,OW1409X,2023-11-06,5383,SARS-CoV-2 EU.4.13 lineage,
106,Quest,,,2023-11-06,5383,SARS-CoV-2 EU.4.13 lineage,
107,LabCorp,Sequencing study identifier|LC Identifier,LC5670,2025-02-17,9933,SARS-CoV-2 DK.4.4 lineage; DK.4.4,
108,LabCorp,Sequencing study identifier|LC Identifier,LC6117,2025-01-08,4954,SARS-CoV-2 Z.2.16 lineage; Z.2.16,
109,LabCorp,Sequencing study identifier,LC6615,2026-02-17,1934,SARS-CoV-2 SLK.5.9 lineage; SLK.5.9,
110,Helix,Sequencing study identifier,VSX-A8057,2026-03-07,VSX-A8057,SARS-CoV-2 T.3.6.3 lineage,
110,Helix,Age,31,2026-03-07,VSX-A8057,SARS-CoV-2 T.3.6.3 lineage,
110,Helix,,,2026-03-07,VSX-A8057,SARS-CoV-2 T.3.6.3 lineage,
111,Helix,Sequencing study identifier,VSX-A6110,2024-07-25,VSX-A6110,SARS-CoV-2 VZ.1.13 lineage,
111,Helix,Age,64,2024-07-25,VSX-A6110,SARS-CoV-2 VZ.1.13 lineage,
111,Helix,,,2024-07-25,VSX-A6110,SARS-CoV-2 VZ.1.13 lineage,
112,Helix,Sequencing study identifier,VSX-A5330,2025-07-13,VSX-A5330,SARS-CoV-2 O.3.12 lineage,
112,Helix,Age,35,2025-07-13,VSX-A5330,SARS-CoV-2 O.3.12 lineage,
112,Helix,,,2025-07-13,VSX-A5330,SARS-CoV-2 O.3.12 lineage,
